These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11730828)
1. The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. Haines CJ; Yim SF; Sanderson JE Atherosclerosis; 2001 Dec; 159(2):467-70. PubMed ID: 11730828 [TBL] [Abstract][Full Text] [Related]
2. Anti-ischemic action of estrogen-progestogen continuous combined hormone replacement therapy in postmenopausal women with established angina pectoris: a randomized, placebo-controlled, double-blind, parallel-group trial. Sanderson JE; Haines CJ; Yeung L; Yip GW; Tang K; Yim SF; Jorgensen LN; Woo J J Cardiovasc Pharmacol; 2001 Sep; 38(3):372-83. PubMed ID: 11486242 [TBL] [Abstract][Full Text] [Related]
3. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213 [TBL] [Abstract][Full Text] [Related]
5. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Squadrito F; Altavilla D; Crisafulli A; Saitta A; Cucinotta D; Morabito N; D'Anna R; Corrado F; Ruggeri P; Frisina N; Squadrito G Am J Med; 2003 Apr; 114(6):470-6. PubMed ID: 12727580 [TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523 [TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Teede HJ; Liang YL; Kotsopoulos D; Zoungas S; Cravent R; McGrath BP Clin Endocrinol (Oxf); 2001 Nov; 55(5):673-82. PubMed ID: 11894980 [TBL] [Abstract][Full Text] [Related]
8. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M Menopause; 1999; 6(1):36-42. PubMed ID: 10100178 [TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women. Kaleli B; Yildirim B; Demir S; Alatas E Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255 [TBL] [Abstract][Full Text] [Related]
10. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023 [TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens. Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490 [TBL] [Abstract][Full Text] [Related]
12. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073 [TBL] [Abstract][Full Text] [Related]
13. Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries. Sitges M; Heras M; Roig E; Durán M; Masotti M; Zurbano MJ; Roqué M; Sanz G Eur Heart J; 2001 Nov; 22(22):2116-24. PubMed ID: 11686668 [TBL] [Abstract][Full Text] [Related]
14. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women. Salobir BG; Keber I; Vrabic L Fertil Steril; 2002 Dec; 78(6):1178-83. PubMed ID: 12477508 [TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy in women with angina with normal coronary arteriograms. Pathogenetic or symptomatic therapy? Rosano GM; Fini M; Mercuro G Eur Heart J; 2001 Nov; 22(22):2051-4. PubMed ID: 11686662 [No Abstract] [Full Text] [Related]
18. Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endothelium-dependent vasodilatation and arterial wall compliance. Mares P; Dauzat M; Abramovici Y Maturitas; 2002 May; 42(1):45-53. PubMed ID: 12020979 [TBL] [Abstract][Full Text] [Related]
19. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Lieberman EH; Gerhard MD; Uehata A; Walsh BW; Selwyn AP; Ganz P; Yeung AC; Creager MA Ann Intern Med; 1994 Dec; 121(12):936-41. PubMed ID: 7978718 [TBL] [Abstract][Full Text] [Related]
20. Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease. Vitale C; Fini M; Leonardo F; Rossini P; Cerquetani E; Onorati D; Rosano GM Maturitas; 2001 Dec; 40(3):239-45. PubMed ID: 11731185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]